Benitec Biopharma Inc. Common Stock (BNTC)
PHARMACEUTICAL PREPARATIONS
Benitec Biopharma Inc. Common Stock (BNTC) is listed on Nasdaq, where it has traded since July 11, 2012.
- Listed On
- Nasdaq
- Listed Since
- July 11, 2012
- Employees
- 24
- Market Cap
- $307M
About Benitec Biopharma Inc. Common Stock
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 84 institutions reported holding BNTC, with 33.1 million shares worth $443.3 million in aggregate. The largest reported holder was Suvretta Capital Management, with 11.5 million shares worth $154.5 million. Of the 5 largest holders listed below, 1 added shares, 1 reduced its position and 3 held their positions unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Suvretta Capital Management | 11,548,351 | $155M | Unchanged |
| Janus Henderson (Jupiter Topco) | 2,478,547 | $33M | Reduced 13.83% |
| Franklin Resources | 2,412,888 | $32M | Added 1.46% |
| Adage Capital Partners GP | 2,120,672 | $28M | Unchanged |
| RA Capital Management | 1,850,000 | $25M | Unchanged |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is BNTC?
Benitec Biopharma Inc. Common Stock (BNTC) is listed on Nasdaq, where it has traded since July 11, 2012.
Who are the largest institutional holders of BNTC?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of BNTC were Suvretta Capital Management, Janus Henderson (Jupiter Topco) and Franklin Resources.
How many institutions own BNTC?
84 institutions reported a position in BNTC for the quarter ended June 30, 2026, worth $443.3 million in total.
Did institutions buy or sell BNTC last quarter?
Of the 5 largest reported holders, 1 added shares, 1 reduced its position and 3 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for BNTC.
Every reported institutional holder, plus insider and congressional trades in BNTC, on SentiSense.